.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
UBS
Argus Health
Harvard Business School
Farmers Insurance
Fuji
Colorcon
McKinsey
US Army

Generated: December 17, 2017

DrugPatentWatch Database Preview

PENNSAID Drug Profile

« Back to Dashboard

Which patents cover Pennsaid, and when can generic versions of Pennsaid launch?

Pennsaid is a drug marketed by Horizon Pharma and Nuvo Pharms Inc and is included in two NDAs. There are nineteen patents protecting this drug and two Paragraph IV challenges.

This drug has eighteen patent family members in fourteen countries.

The generic ingredient in PENNSAID is diclofenac sodium. There are forty-seven drug master file entries for this compound. Eighty-nine suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Nuvo Pharms IncPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL020947-001Nov 4, 2009DISCNYesNo► Subscribe► Subscribe► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Horizon PharmaPENNSAIDdiclofenac sodiumSOLUTION;TOPICAL204623-001Jan 16, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for PENNSAID

Drugname Dosage Strength RLD Submissiondate
diclofenac sodiumTopical Solution2.0%Pennsaid6/3/2014
diclofenac sodiumTopical Solution1.5%Pennsaid7/11/2012

International Patent Family for Tradename: PENNSAID

Country Document Number Estimated Expiration
New Zealand577020► Subscribe
South Africa200903135► Subscribe
Russian Federation2463038► Subscribe
Denmark2086504► Subscribe
Japan2010506952► Subscribe
Russian Federation2009118392► Subscribe
China101588791► Subscribe
Canada2666398► Subscribe
BrazilPI0717769► Subscribe
European Patent Office2626063► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Covington
Baxter
Colorcon
Express Scripts
Fuji
Deloitte
US Department of Justice
Queensland Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot